Rapport Therapeutics, Inc.
Ticker: 2012593
values in millions
| Period | Q1 FY26 |
|---|---|
| INCOME | |
| Revenue | 20.00 |
| Total Income | 20.00 |
| EXPENSES | |
| Expenditure | 44.22 |
| PROFIT | |
| Net Profit | -19.86 |
| KEY METRICS | |
| OPM % | -100.00% |
| NPM % | -99.28% |
| EPS | -0.42 |
Corporate Events
Board MeetingRAPP
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II direct…
SEC Filing ↗